Eikon Therapeutics, Inc. (EIKN)

CIK 1861123 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eikon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 202640001193125-26-385268
Aug 14, 20268-K0001193125-26-349936
Aug 13, 20268-K0001193125-26-349154
Aug 13, 202610-Q0001193125-26-349185
Aug 6, 2026SCHEDULE 13G/A0000315066-26-001987
Aug 3, 20268-K0001193125-26-330710
Jun 15, 202630001193125-26-271167
Jun 10, 20268-K0001193125-26-265861
Jun 1, 20268-K0001193125-26-249725
May 15, 2026SCHEDULE 13G0001720215-26-000006
May 13, 2026SCHEDULE 13G0001193125-26-221988
May 11, 20268-K0001193125-26-216744
May 11, 202610-Q0001193125-26-216791
May 6, 2026SCHEDULE 13G0000315066-26-001183
Apr 29, 2026SCHEDULE 13G0002052113-26-000458
Mar 30, 20268-K0001193125-26-130449
Mar 30, 202610-K0001193125-26-130395
Mar 4, 202640001193125-26-091767
Mar 4, 202640001193125-26-091771
Mar 4, 202640001193125-26-091798
Mar 4, 202640001193125-26-091787
Mar 4, 202640001193125-26-091783
Mar 4, 202640001193125-26-091770
Mar 4, 202640001193125-26-091779
Feb 18, 2026SCHEDULE 13G0001999371-26-003632